Elevated serum α-synuclein autoantibodies in patients with Parkinson’s disease relative to Alzheimer’s disease and controls
Early diagnosis of neurodegenerative diseases is of paramount importance for successful treatment. Lack of sensitive and early biomarkers for diagnosis of diseases like Parkinson’s disease (PD) is a handicapping problem for all movement disorders specialists. Using serum autoimmune antibodies (AI...
Main Authors: | Shalash, Ali, Salama, Mohamed, Makar, Marianne, Roushdy, Tamer, Elrassas, Hannan hany, Mohamed, Wael Mohamed Yousef, ElBalkimy, Mahmoud, Abu Donia, Mohamed |
---|---|
Format: | Article |
Language: | English English |
Published: |
Frontiers Media S.A.
2017
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/60803/ http://irep.iium.edu.my/60803/ http://irep.iium.edu.my/60803/ http://irep.iium.edu.my/60803/1/Alpha%20Syneculin%20Frontier.pdf http://irep.iium.edu.my/60803/7/60803_Elevated%20serum_scopus.pdf |
Similar Items
-
Tubulin and tau: Possible targets for diagnosis of Parkinson’s and Alzheimer’s diseases
by: Salama, Mohamed, et al.
Published: (2018) -
Parkinson's disease
by: Pearce
Published: (1999) -
Alzheimer's disease a medical companion
by: BURNS
Published: (1995) -
Genetic underpinnings in Alzheimer’s disease –
A review
by: Moustafa, Ahmed A., et al.
Published: (2017) -
Alzheimer disease: gene therapy and natural product research
by: Doolaanea, Abd Almonem, et al.
Published: (2018)